纳米材料介导的 CAR-T 增强用于肝细胞癌:革新免疫治疗策略
Nanomaterials Mediated Enhancement of CAR-T for HCC: Revolutionizing Immunotherapy Strategies.
肝细胞癌(HCC)因其侵袭性和对常规治疗的耐药性而带来重大挑战。
52.9分
★★★☆☆
FRONTIER PAPERS
Nanomaterials Mediated Enhancement of CAR-T for HCC: Revolutionizing Immunotherapy Strategies.
肝细胞癌(HCC)因其侵袭性和对常规治疗的耐药性而带来重大挑战。
共 1 条
MEMBER ACCOUNT
登录成功会直接打开下一页。